Connect with us

Company News

Glenmark Pharma Reports of Zero Observations from USFDA for Baddi Plant

Glenmark Pharma reports that the US health regulator cleared the company’s Baddi plant with zero observations. The health regulator had begun its inspection of facility on September 17. But Glenmark made no comment w.r.t US FDA inspection closure, sources said. – Money Control

Copyright © 2024 Medical Buyer

error: Content is protected !!